The burgeoning field of peptide-based therapeutics demands innovative strategies for the design and delivery of these potent biomolecules. Tailoring copyright to accurately target disease while ensuring efficient administration to cellular sites remains a major challenge. Scientists are continuously developing novel methods to address these hurdles